The data reveal that the inhibition activity of I13 against CML cells harboring T315I-mutated or wild-type BCR-ABL may be associated with the induction of cell differentiation. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.